Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

SNOA Sonoma Pharmaceuticals Inc

0,1762

-0,0228 (-11,46%)

Vor Marktöffnung

Zuletzt aktualisiert: 11:23:55

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Sonoma Pharmaceuticals (NASDAQ:SNOA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Sonoma Pharmaceuticals Charts.

Sonoma Pharmaceuticals (NASDAQ:SNOA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Sonoma Pharmaceuticals Charts.

News Sonoma Pharmaceuticals Inc

Form 8-K - Current report
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 8 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 10 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 9 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 29 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 29 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 29 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 29 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 29 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 15 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Dienstag 21 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Weitere Sonoma Pharmaceuticals Inc News-Artikel

Voice Token (MUTE)

Franklin Growth Allocati...

International Marketing & Sales

FT Vest Nasdaq 100 Buffe...

Vontobel Financial Produ...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen